ACEMID cohort study: protocol of a prospective cohort study using 3D total body photography for melanoma imaging and diagnosis
Introduction Three-dimensional (3D) total body photography may improve early detection of melanoma and facilitate surveillance, leading to better prognosis and lower healthcare costs. The Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID) cohort study will assess long-term ou...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/13/9/e072788.full |
| _version_ | 1797667966978883584 |
|---|---|
| author | Rory Wolfe Monika Janda Rashidul Alam Mahumud Anne E Cust Uyen Koh Rachael Morton Graham Mann Grace Kwaan Victoria Mar Pablo Fernández-Peñas Elizabeth Payne Caitlin Horsham Maithili Sashindranath Hans Peter Soyer |
| author_facet | Rory Wolfe Monika Janda Rashidul Alam Mahumud Anne E Cust Uyen Koh Rachael Morton Graham Mann Grace Kwaan Victoria Mar Pablo Fernández-Peñas Elizabeth Payne Caitlin Horsham Maithili Sashindranath Hans Peter Soyer |
| author_sort | Rory Wolfe |
| collection | DOAJ |
| description | Introduction Three-dimensional (3D) total body photography may improve early detection of melanoma and facilitate surveillance, leading to better prognosis and lower healthcare costs. The Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID) cohort study will assess long-term outcomes from delivery of a precision strategy of monitoring skin lesions using skin surface imaging technology embedded into health services across Australia.Methods and analysis A prospective cohort study will enrol 15 000 participants aged 18 years and above, across 15 Australian sites. Participants will attend study visits according to their melanoma risk category: very high risk, high risk or low/average risk, every 6, 12 and 24 months, respectively, over 3 years. Participants will undergo 3D total body photography and dermoscopy imaging at study visits. A baseline questionnaire will be administered to collect sociodemographic, phenotypic, quality of life and sun behaviour data. A follow-up questionnaire will be administered every 12 months to obtain changes in sun behaviour and quality of life. A saliva sample will be collected at the baseline visit from a subsample.Ethics and dissemination The ACEMID cohort study was approved by the Metro South Health Human Research Ethics Committee (approval number: HREC/2019/QMS/57206) and the University of Queensland Human Research Ethics Committee (approval number: 2019003077). The findings will be reported through peer-reviewed and lay publications and presentations at conferences.Trial registration number ACTRN12619001706167. |
| first_indexed | 2024-03-11T20:22:13Z |
| format | Article |
| id | doaj.art-48c31870d854459199dc2f3127a56778 |
| institution | Directory Open Access Journal |
| issn | 2044-6055 |
| language | English |
| last_indexed | 2024-03-11T20:22:13Z |
| publishDate | 2023-09-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj.art-48c31870d854459199dc2f3127a567782023-10-03T00:25:07ZengBMJ Publishing GroupBMJ Open2044-60552023-09-0113910.1136/bmjopen-2023-072788ACEMID cohort study: protocol of a prospective cohort study using 3D total body photography for melanoma imaging and diagnosisRory Wolfe0Monika Janda1Rashidul Alam Mahumud2Anne E Cust3Uyen Koh4Rachael Morton5Graham Mann6Grace Kwaan7Victoria Mar8Pablo Fernández-Peñas9Elizabeth Payne10Caitlin Horsham11Maithili Sashindranath12Hans Peter Soyer13School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, AustraliaCentre for Health Services Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia3 Health Economics Research, Health Systems and Population Studies Division, International Centre for Diarrhoeal Disease Research, Dhaka, BangladeshMelanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFrazer Institute, Dermatology Research Centre, The University of Queensland, Brisbane, Queensland, AustraliaNational Health and Medical Research Council (NHMRC) Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, AustraliaMelanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia5Australian Mesothelioma Registry, Sydney, AustraliaVictorian Melanoma Service, Alfred Health, Melbourne, Victoria, AustraliaDepartment of Dermatology, Westmead Hospital, Westmead, New South Wales, AustraliaFrazer Institute, Dermatology Research Centre, The University of Queensland, Brisbane, Queensland, AustraliaCentre for Health Services Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, AustraliaSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, AustraliaFrazer Institute, Dermatology Research Centre, The University of Queensland, Brisbane, Queensland, AustraliaIntroduction Three-dimensional (3D) total body photography may improve early detection of melanoma and facilitate surveillance, leading to better prognosis and lower healthcare costs. The Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID) cohort study will assess long-term outcomes from delivery of a precision strategy of monitoring skin lesions using skin surface imaging technology embedded into health services across Australia.Methods and analysis A prospective cohort study will enrol 15 000 participants aged 18 years and above, across 15 Australian sites. Participants will attend study visits according to their melanoma risk category: very high risk, high risk or low/average risk, every 6, 12 and 24 months, respectively, over 3 years. Participants will undergo 3D total body photography and dermoscopy imaging at study visits. A baseline questionnaire will be administered to collect sociodemographic, phenotypic, quality of life and sun behaviour data. A follow-up questionnaire will be administered every 12 months to obtain changes in sun behaviour and quality of life. A saliva sample will be collected at the baseline visit from a subsample.Ethics and dissemination The ACEMID cohort study was approved by the Metro South Health Human Research Ethics Committee (approval number: HREC/2019/QMS/57206) and the University of Queensland Human Research Ethics Committee (approval number: 2019003077). The findings will be reported through peer-reviewed and lay publications and presentations at conferences.Trial registration number ACTRN12619001706167.https://bmjopen.bmj.com/content/13/9/e072788.full |
| spellingShingle | Rory Wolfe Monika Janda Rashidul Alam Mahumud Anne E Cust Uyen Koh Rachael Morton Graham Mann Grace Kwaan Victoria Mar Pablo Fernández-Peñas Elizabeth Payne Caitlin Horsham Maithili Sashindranath Hans Peter Soyer ACEMID cohort study: protocol of a prospective cohort study using 3D total body photography for melanoma imaging and diagnosis BMJ Open |
| title | ACEMID cohort study: protocol of a prospective cohort study using 3D total body photography for melanoma imaging and diagnosis |
| title_full | ACEMID cohort study: protocol of a prospective cohort study using 3D total body photography for melanoma imaging and diagnosis |
| title_fullStr | ACEMID cohort study: protocol of a prospective cohort study using 3D total body photography for melanoma imaging and diagnosis |
| title_full_unstemmed | ACEMID cohort study: protocol of a prospective cohort study using 3D total body photography for melanoma imaging and diagnosis |
| title_short | ACEMID cohort study: protocol of a prospective cohort study using 3D total body photography for melanoma imaging and diagnosis |
| title_sort | acemid cohort study protocol of a prospective cohort study using 3d total body photography for melanoma imaging and diagnosis |
| url | https://bmjopen.bmj.com/content/13/9/e072788.full |
| work_keys_str_mv | AT rorywolfe acemidcohortstudyprotocolofaprospectivecohortstudyusing3dtotalbodyphotographyformelanomaimaginganddiagnosis AT monikajanda acemidcohortstudyprotocolofaprospectivecohortstudyusing3dtotalbodyphotographyformelanomaimaginganddiagnosis AT rashidulalammahumud acemidcohortstudyprotocolofaprospectivecohortstudyusing3dtotalbodyphotographyformelanomaimaginganddiagnosis AT anneecust acemidcohortstudyprotocolofaprospectivecohortstudyusing3dtotalbodyphotographyformelanomaimaginganddiagnosis AT uyenkoh acemidcohortstudyprotocolofaprospectivecohortstudyusing3dtotalbodyphotographyformelanomaimaginganddiagnosis AT rachaelmorton acemidcohortstudyprotocolofaprospectivecohortstudyusing3dtotalbodyphotographyformelanomaimaginganddiagnosis AT grahammann acemidcohortstudyprotocolofaprospectivecohortstudyusing3dtotalbodyphotographyformelanomaimaginganddiagnosis AT gracekwaan acemidcohortstudyprotocolofaprospectivecohortstudyusing3dtotalbodyphotographyformelanomaimaginganddiagnosis AT victoriamar acemidcohortstudyprotocolofaprospectivecohortstudyusing3dtotalbodyphotographyformelanomaimaginganddiagnosis AT pablofernandezpenas acemidcohortstudyprotocolofaprospectivecohortstudyusing3dtotalbodyphotographyformelanomaimaginganddiagnosis AT elizabethpayne acemidcohortstudyprotocolofaprospectivecohortstudyusing3dtotalbodyphotographyformelanomaimaginganddiagnosis AT caitlinhorsham acemidcohortstudyprotocolofaprospectivecohortstudyusing3dtotalbodyphotographyformelanomaimaginganddiagnosis AT maithilisashindranath acemidcohortstudyprotocolofaprospectivecohortstudyusing3dtotalbodyphotographyformelanomaimaginganddiagnosis AT hanspetersoyer acemidcohortstudyprotocolofaprospectivecohortstudyusing3dtotalbodyphotographyformelanomaimaginganddiagnosis |